Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Qiagen highlights positive trends in 2015 financial report

Qiagen highlights positive trends in 2015 financial report

3rd February 2016

Qiagen has announced its financial results for 2015, during which it delivered an adjusted net sales total of $1.28 billion (877.44 million pounds).

This represented a year-on-year increase of three percent on a constant exchange rate basis, or down by five percent in nominal terms, following a fourth-quarter performance that was in line with expectations.

Solid growth was achieved within the company's academia, pharma and applied testing business divisions, though its molecular diagnostics saw a dampened performance in the second half of the year.

The company has already announced plans to support incremental investments during 2016 to enhance its current portfolio, with moves to strengthen commercialisation of products such as the QuantiFERON-TB tests and the GeneReader NGS System.

As such, adjusted net sales are expected to rise approximately six percent at constant exchange rates in 2016.

Peer Schatz, chief executive officer of Qiagen, said: "Qiagen made significant progress in 2015 on initiatives to accelerate innovation and growth, and we are confident these efforts will become more apparent in 2016 and the coming years."ADNFCR-8000103-ID-801811789-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.